Search research articles
Contact Us
Filters
Showing results (101-110 of 969) with videos related to
Page
of 97
Sort By:
The Journal of Rheumatology
|
September 11, 2003
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus
Dominique Ibañez, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology
|
April 1, 1986
Rheumatoid pleural effusion: lack of response to intrapleural corticosteroid
M L Russell, D D Gladman, S Mintz
The Journal of Rheumatology
|
December 19, 2007
Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort
Vinod Chandran, Catherine T Schentag, Dafna D Gladman
The Journal of Rheumatology
|
February 13, 2002
Systemic lupus erythematosus disease activity index 2000
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz
The Journal of Rheumatology
|
April 1, 1995
Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model
D D Gladman, V T Farewell, C Nadeau
The Journal of Rheumatology
|
May 1, 1980
Neuropsychiatric lupus
T Abel, D D Gladman, M B Urowitz
Current Opinion in Rheumatology
|
February 2, 2013
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign
Zahi Touma, Dafna D Gladman, Murray B Urowitz
Lupus
|
October 8, 2013
Damage in lupus patients--what have we learned so far?
L Eder, M B Urowitz, D D Gladman
Seminars in Arthritis and Rheumatism
|
November 13, 2018
How can we define low disease activity in systemic lupus erythematosus?
Konstantinos Tselios, Dafna D Gladman, Murray B Urowitz
The Journal of Rheumatology
|
November 3, 2012
On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting
Amit Garg, Dafna D Gladman, Philip J Mease
Page
of 97
Search research articles
Search
Showing results (101-110 of 969) with videos related to
Sort By:
Page
of 97
The Journal of Rheumatology
|
September 11, 2003
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus
Dominique Ibañez, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology
|
April 1, 1986
Rheumatoid pleural effusion: lack of response to intrapleural corticosteroid
M L Russell, D D Gladman, S Mintz
The Journal of Rheumatology
|
December 19, 2007
Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort
Vinod Chandran, Catherine T Schentag, Dafna D Gladman
The Journal of Rheumatology
|
February 13, 2002
Systemic lupus erythematosus disease activity index 2000
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz
The Journal of Rheumatology
|
April 1, 1995
Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model
D D Gladman, V T Farewell, C Nadeau
The Journal of Rheumatology
|
May 1, 1980
Neuropsychiatric lupus
T Abel, D D Gladman, M B Urowitz
Current Opinion in Rheumatology
|
February 2, 2013
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign
Zahi Touma, Dafna D Gladman, Murray B Urowitz
Lupus
|
October 8, 2013
Damage in lupus patients--what have we learned so far?
L Eder, M B Urowitz, D D Gladman
Seminars in Arthritis and Rheumatism
|
November 13, 2018
How can we define low disease activity in systemic lupus erythematosus?
Konstantinos Tselios, Dafna D Gladman, Murray B Urowitz
The Journal of Rheumatology
|
November 3, 2012
On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting
Amit Garg, Dafna D Gladman, Philip J Mease
Page
of 97